Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Andri A. Novik"'
Autor:
Sergei Voloshin, Anton V. Kishtovich, Gennadi N. Bisaga, Andri A. Novik, Tatiana I. Ionova, Boris V. Afanasiev, Yury N. Fedotov, Olga A. Malysheva, Inna V. Vereschagina, Lubov V. Chelombit, Igor A. Lisukov, Denis A. Fedorenko, AD Kulagin, Yury L. Shevchenko, Vladimir Y. Melnichenko
Publikováno v:
Blood. 104:1875-1875
Objectives: HDCT+ASCT is a new and promising therapy for MS patients. Among a number of questions are the terms of conducting HDCT+ASCT. According to our concept there are 3 strategies of HDCT+ASCT depending on terms of disease stage: early, conventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dc3d0902c9a1dd4f70685a51190e0fd
https://doi.org/10.1182/blood.v104.11.1875.1875
https://doi.org/10.1182/blood.v104.11.1875.1875
Autor:
Tatiana I. Ionova, Nina E. Osipova, Denis A. Fedorenko, Olga S. Uspenskaya, Andri A. Novik, Anton V. Kishtovich
Publikováno v:
Blood. 104:3125-3125
Background: It is quite obvious that population of new Hodgkin’s disease (HD) patients is heterogeneous in terms of clinical characteristics. Therefore stratification of patients is necessary to select appropriate treatment regimen. It was shown th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2383d4a48fbcd99276be2c8b34b90a5b
https://doi.org/10.1182/blood.v104.11.3125.3125
https://doi.org/10.1182/blood.v104.11.3125.3125